Dementia
  • Article
  • Jun 23 2022

A researcher at the UK’s Sanders-Brown Center on Aging is one of several experts in the field who recently discussed the use of two popular screening tests for dementia and Alzheimer’s disease.

  • Article
  • Jun 14 2022

Research published from the Sanders-Brown Center on Aging is providing the most definitive assessment yet of the prevalence of a form of dementia classified in 2019 and now known as LATE.

  • Article
  • Mar 16 2022

The world’s first clinical trial for a form of dementia identified in 2019 is officially underway by researchers at the University of Kentucky's Sanders-Brown Center on Aging.

  • Article
  • Feb 10 2022

Linda J. Van Eldik, Ph.D., director of the Sanders-Brown Center on Aging has been appointed to the National Advisory Council on Aging (NACA) among many notable leaders from across the country.

  • Article
  • Feb 2 2022

A team of researchers from the UK's Sanders-Brown Center on Aging (SBCoA) is working to identify new proteins that are destructive to the brain.

  • Article
  • Nov 11 2021

The center received a five-year grant renewal from the National Institutes of Health (NIH), with an award total more than $6 million. 

  • Video
  • Nov 8 2021

For this "UK at the Half," University of Kentucky Sanders-Brown Center on Aging Director Linda Van Eldik talks about the life-changing — and lifesaving — work that the center does.

  • Podcast
  • Nov 8 2021

On this episode of "Behind the Blue," Sanders-Brown Center on Aging Director Linda Van Eldik joins UK Public Relations and Strategic Communications' Hillary Smith to discuss the larger game plan of finding a cure for Alzheimer’s and dementia.

  • Article
  • Apr 27 2021

A multi-disciplinary collaboration led by Dr. Peter Sawaya from the Sanders-Brown Center on Aging are in the process of producing a series of videos, aimed at primary caregivers for family members and loved ones living with dementia.

  • Article
  • Apr 1 2021

The educational film titled, Spark, delves deeper into the disease, its biology, myriad of clinical symptoms and its impact on both the person with LBD and the primary caregiver. A post-screening panel will feature doctors from the Kentucky Neuroscience Institute.